首页> 外文期刊>Genetics in medicine >Integration of targeted sequencing and NIPT into clinical practice in a Chinese family with maple syrup urine disease
【24h】

Integration of targeted sequencing and NIPT into clinical practice in a Chinese family with maple syrup urine disease

机译:用枫糖浆尿疾病将有针对性测序和NIPT临床实践的整合

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose:This article demonstrates a prominent noninvasive prenatal approach to assist the clinical diagnosis of a single-gene disorder disease, maple syrup urine disease, using targeted sequencing knowledge from the affected family.Methods:The method reported here combines novel mutant discovery in known genes by targeted massively parallel sequencing with noninvasive prenatal testing.Results:By applying this new strategy, we successfully revealed novel mutations in the gene BCKDHA (Ex2-4dup and c.392A>G) in this Chinese family and developed a prenatal haplotype-assisted approach to noninvasively detect the genotype of the fetus (transmitted from both parents).Conclusion:This is the first report of integration of targeted sequencing and noninvasive prenatal testing into clinical practice. Our study has demonstrated that this massively parallel sequencing-based strategy can potentially be used for single-gene disorder diagnosis in the future.
机译:目的:本文展示了一种突出的非侵入性产前方法,可帮助来自受影响的家庭的靶向测序知识的单一基因紊乱疾病的临床诊断。方法:这里报道的方法结合了新的突变体发现在已知的基因中 通过针对具有非侵入性产前检测的大规模平行测序。结果:通过应用这种新策略,我们在这家中国家庭中成功揭示了基因Bckdha(Ex2-4dup和C.392a> g)的新突变,并开发了产前单倍型辅助方法 为了非侵入地检测胎儿的基因型(从父母两种)。结论:这是将靶向测序和非侵入性产前检测整合到临床实践中的第一报告。 我们的研究表明,这种基于大规模的平行测序的策略可能用于未来的单基因障碍诊断。

著录项

  • 来源
    《Genetics in medicine》 |2014年第8期|共7页
  • 作者单位

    Department of Obstetrics and Gynecology Chinese PLA General Hospital Beijing China;

    BGI-Shenzhen Shenzhen China China Clinical Lab of Shenzhen BGI-Health Shenzhen China;

    BGI-Shenzhen Shenzhen China Shenzhen Municipal Key Laboratory of Birth Defects Screening and;

    Department of Obstetrics and Gynecology Chinese PLA General Hospital Beijing China;

    BGI-Shenzhen Shenzhen China China Clinical Lab of Shenzhen BGI-Health Shenzhen China;

    BGI-Shenzhen Shenzhen China Shenzhen Municipal Key Laboratory of Birth Defects Screening and;

    BGI-Shenzhen Shenzhen China Shenzhen Municipal Key Laboratory of Birth Defects Screening and;

    BGI-Shenzhen Shenzhen China China Clinical Lab of Shenzhen BGI-Health Shenzhen China;

    BGI-Shenzhen Shenzhen China China Clinical Lab of Shenzhen BGI-Health Shenzhen China;

    China Clinical Lab of Beijing BGI-Health Beijing China;

    Department of Obstetrics and Gynecology Chinese PLA General Hospital Beijing China;

    BGI-Shenzhen Shenzhen China China Clinical Lab of Shenzhen BGI-Health Shenzhen China;

    BGI-Shenzhen Shenzhen China China Clinical Lab of Shenzhen BGI-Health Shenzhen China;

    BGI-Shenzhen Shenzhen China China Clinical Lab of Shenzhen BGI-Health Shenzhen China;

    BGI-Shenzhen Shenzhen China China Clinical Lab of Shenzhen BGI-Health Shenzhen China;

    China Clinical Lab of Beijing BGI-Health Beijing China;

    China Clinical Lab of Beijing BGI-Health Beijing China;

    China Clinical Lab of Beijing BGI-Health Beijing China;

    BGI-Shenzhen Shenzhen China Shenzhen Municipal Key Laboratory of Birth Defects Screening and;

    BGI-Shenzhen Shenzhen China China Clinical Lab of Shenzhen BGI-Health Shenzhen China;

    BGI-Shenzhen Shenzhen China;

    BGI-Shenzhen Shenzhen China Shenzhen Municipal Key Laboratory of Birth Defects Screening and;

    Department of Obstetrics and Gynecology Chinese PLA General Hospital Beijing China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学遗传学;
  • 关键词

    massively parallel sequencing; MSUD; noninvasive prenatal testing; single-gene disorders; target-gene capture;

    机译:大规模平行测序;MSUD;非侵入性产前试验;单基因紊乱;靶基因捕获;
  • 入库时间 2022-08-20 03:12:27

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号